Pfizer’s drug Paxlovid has been approved in the EU since January 2022 and can now be prescribed by doctors in Germany.
Freiburg – In addition to vaccines, an elementary building block in the fight against a pandemic is medication that can be used when people have already been infected with Covid-19. One problem so far has been that almost exclusively antibody-based therapies have been available that are used in clinics. The emphasis is on “were”, because: A corona drug that was specially developed for outpatient therapy has now been approved in Germany.
BW24* provides information about the Corona drug “Paxlovid” produced in BW
Paxlovid is a tablet designed to prevent severe disease progression: Doctors can prescribe it to Covid patients who are at risk of developing a severe course. The preparation from Pfizer is taken orally twice a day for a maximum of five days and should be prescribed as soon as possible after the diagnosis. The primary aim of Paxlovid is to treat the elderly and people with certain pre-existing conditions. * BW24 is an offer from IPPEN.MEDIA.
